Our Statement on Deceased Donor Islet Cell Availability & The ISLET Act
Curing type 1 diabetes (T1D) is Breakthrough T1D’s number one priority. As the leading global T1D research and advocacy organization, we are currently funding over $450 million in cures research in 23 countries. Everything we do is focused on making cures happen for the T1D community, sooner.
U.S. National Library of Medicine · Public Domain